About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,707 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,707 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2001-2020 of 3,707 trials

CompletedWOE of Anti-CD20 TherapiesThe nature, intensity, and prevalence of this wearing-off effect remain poorly understood.NCT06121349·East Hanover, New Jersey CompletedInteroception and Sense of Movement in the Patient With Multiple SclerosisTo evaluate the effectiveness of an experimental rehabilitative protocol with specific tasks for the improvement of body awareness and the motor scheme in the patient with…NCT03711968·Rome CompletedATX-MS-1467 in Multiple SclerosisThis is a multi-center, open-label, single arm, baseline-controlled Phase 2a trial to evaluate the clinical and biological effects of ATX-MS-1467 in subjects with relapsing…NCT01973491·Darmstadt UnknownA Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple SclerosisThe purpose of this study is to assess whether Multiple Sclerosis patients treated with Gilenya show a beneficial change over time in bone mass density and bone turnover markers…NCT01811290·Kirkland, Washington

Related Searches

Data from ClinicalTrials.govTerms

CompletedPower Over Pain (POP) StudyMany individuals with multiple sclerosis (MS), spinal cord injury (SCI), acquired amputation (AMP), muscular dystrophy (MD), and low back pain (LBP) experience pain.NCT01800604·Seattle, Washington

CompletedThe Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple SclerosisCurrent evidence suggests that cigarette smoke increases disease progression in people with multiple sclerosis (PwMS) and worsen their symptoms.NCT05046535·Amman

TerminatedClemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple SclerosisRationale: Clemastine fumarate has been identified as potential remyelinating therapy for multiple sclerosis (MS).NCT05338450·Amsterdam

CompletedAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisThe main purpose of this study is to evaluate the safety and feasibility of regenerative therapy with mesenchymal stem cells from adipose tissue, administered intravenously in…NCT01056471·Málaga, Málaga and 1 other

Not yet recruitingIntermittent Theta-Burst Stimulation for Lower-Limb Spasticity and Pain in Multiple SclerosisSpasticity and neuropathic pain are frequent and disabling symptoms of multiple sclerosis.NCT07786506·Bratislava

CompletedNutritional Counselling for Patients at Kasr AlAiny Multiple Sclerosis Clinic: an Intervention StudyEligible Multiple sclerosis patients attending Kasr AlAiny Multiple Sclerosis Clinic will be randomly allocated to either the intervention or control group by randomized block…NCT04217564·Cairo

CompletedhaMSter: a Novel Smartphone Communication Tool for People With MShaMSter is a smartphone app that tracks validated patient reported outcome measures (PROMs) in people multiple sclerosis (MS).NCT04555863·Vienna

CompletedPregnancy Exposure Registry for Tysabri®The primary objective of the Registry was to evaluate the outcomes of pregnancy in women with Multiple Sclerosis (MS) or Crohn's Disease (CD) who were exposed to TYSABRI® at any…NCT00472992·Morgantown, West Virginia

CompletedOut of Pocket Cost Communication in Multiple Sclerosis PatientsThis is a prospective randomized controlled trial of a cohort of adult multiple sclerosis (MS) patients visiting an outpatient neurology clinic.NCT04257071·Atlanta, Georgia

Active not recruitingMultiple Sclerosis Falls Insight TrackThe purpose of this study is to develop an application: MS Falls Insight Track (MS FIT) which allows patients to log their falls and near falls, view their MS relevant data and…NCT05837949·San Francisco, California

CompletedExtracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple SclerosisThis randomized controlled trial aimed to investigate the efficacy of Extracorporeal Shock Wave Therapy (ESWT) on plantar somatosensory function, knee joint proprioception, and…NCT07514104·Elâzığ

RecruitingAn Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab TreatmentThe study will evaluate the physical impact of MS from participant's perspective, provide continued access to ocrelizumab and assess the safety and tolerability of ocrelizumab.NCT06675955·Amiens Cedex1 and 43 others

CompletedClinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MSThe humanised IgG4 monoclonal antibody GNbAC1 targets the envelope protein (Env) of the human endogenous multiple sclerosis-associated retrovirus (HERV-W MSRV), which may play a…NCT02782858·Sofia and 11 others

CompletedResilience in Young Adults Newly Diagnosed With Multiple SclerosisThis study aims to fill the gap of knowledge on the biopsychosocial (BPS) characteristics and resilience of young adults newly diagnosed with Multiple Sclerosis, to evaluate the…NCT03825055·Verona, Veneto

CompletedZenapax to Treat Multiple SclerosisThis study will examine the safety and effectiveness of Zenapax (a laboratory-manufactured antibody) in treating multiple sclerosis.NCT00001934·Bethesda, Maryland

CompletedEstablish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear CellsOpen-label, single center, phase I clinical trial to assess the safety, tolerability and preliminary efficacy and in vivo mechanisms of action of i.v. administration of autologous…NCT01414634

PreviousPage 101 of 186Next